Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Johnson & Johnson
< Previous
1
2
3
4
5
Next >
New Global Survey by Johnson & Johnson Finds Most Women Don’t Connect Eye Health Changes with Menopause
October 01, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses
September 10, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
September 02, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
August 31, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
August 10, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference
August 04, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
August 04, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
July 29, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
July 29, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation
July 27, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System
July 22, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award
July 16, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026
July 15, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson reports Q2 2026 results, raises 2026 outlook
July 15, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform
July 08, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida
June 15, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
June 11, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
June 08, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
May 27, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter
May 12, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 11, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
May 05, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
April 30, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
April 27, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
April 21, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026
April 21, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference
April 15, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%
April 14, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
April 14, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
April 10, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1